Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Thorac Cancer · 2025 · PMC12260756 · PMID 40662350

Europe PMC DOI

hedged sentences

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

a nonsignificant trendp = 0.083so close (0.05 < p ≤ 0.1)

Patients with PTV < 350 cm 3 had a 26.0% chance for distant recurrence, while patients with PTV ≥ 350 cm 3 had a 39.7% chance for distant recurrence, showing a nonsignificant trend for prediction of distant recurrence, OR 1.87 (95% CI 0.92–3.82), p = 0.083.

also in 5,406 other papers

showed a trendno p-value reported

In a multivariable analysis shown in Table 3 , smoking status showed a trend toward worse OS and PTV was significantly associated with OS. 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.